N/A
Completed N=780
Treating Low-Income Smokers in the Hospital Emergency Department
Source: ClinicalTrials.gov NCT01328431 ↗Enrolled (actual)
780
Serious AEs
0.0%
Results posted
Aug 2014
Primary outcomePrimary: Biochemical Verification of Tobacco Abstinence — 19; 47 participants
Summary
This study will test the effectiveness of an Emergency Department (ED) initiated tobacco intervention which includes counseling and medication. Our proposed intervention combines a Brief Negotiated Interview (BNI) with initiation of nicotine patch and gum in the ED, as well as a faxed referral to the state's Smokers' Quitline. A 6 week supply of nicotine patches and nicotine gum are provided to subjects in the intervention arm. Subjects randomized to the control arm will receive a brochure from the state's Smokers' Quitline only.
The primary hypothesis is that the intervention will be superior to the control condition in reducing self-reported and biochemically verified 7-day tobacco abstinence at 3 months.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Biochemical Verification of Tobacco Abstinence |
19; 47 | — |
| PRIMARY Self-report of Tobacco Abstinence or Reduction |
34; 63 | — |
| SECONDARY Self-reported Tobacco Reduction or Abstinence |
— | — |
| SECONDARY Health Care Service Utilization |
— | — |
Eligibility Criteria
Inclusion Criteria
- Age > 18 years
- Speaks English
- Willing and able to give informed consent
- >100 cigarettes lifetime
- Current daily or some day smoker
- Smokes > 5 cigarettes/day
- Medicaid or self-pay insurance
Exclusion Criteria
- Too ill or unable to consent
- Not interested in study participation
- Not interested in quitting
- Pregnant, nursing, or trying to conceive
- Current use of tobacco cessation products (patch, gum, inhaler, nasal spray, lozenge, e-cigarette)
- Actively psychotic or mentally ill
- Leaving ED against medical advice
- Investigator discretion
- Lives outside of New Haven County
- Does not have phone with CT area code
- In police custody
- History of allergic reaction to nicotine replacement products
- Currently receiving formal tobacco dependence tx
- Currently taking Zyban, Wellbutrin (bupropion) or Chantix(varenicline)
- Resides in an extended care facility
Data sourced from ClinicalTrials.gov (NCT01328431). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.